Anemia Clinical Trial
— EHFPOfficial title:
THE IMPACT OF THE ENHANCED HOMESTEAD FOOD PRODUCTION PROGRAM ON CHILD HEALTH
Helen Keller International (HKI) has been implementing homestead food production (HFP)
programs in Asia for the past 20 years and has recently begun implementing HFP programs in
Africa as well. In general, these programs target women and are designed to improve maternal
and child health and nutrition outcomes through three primary pathways: 1. Increasing the
availability of micronutrient-rich foods through increased household production of these
foods; 2. Raising income through the sale of surplus production; and 3. Increasing knowledge
and adoption of optimal nutrition practices, including the consumption of micronutrient-rich
foods. Evaluations of HFP programs have consistently demonstrated significant increases in
household production and consumption of micronutrient-rich foods. This increased
consumption, along with improvements in health and nutrition related knowledge, and
increased income, could all contribute to improvements in maternal and child health and
nutrition outcomes. However, to date there has been limited understanding as to how these
types of programs can be optimized to maximize impacts on these outcomes.
In order to better understand the potential of these types of programs to improve maternal
and child health and nutrition outcomes and how this impact may be achieved IFPRI has been
collaborating with HKI to evaluate one of their E-HFP programs in Burkina Faso. The
evaluation considers impact of the program through the three pathways above, and assesses
anthropometric and clinical measures of nutrition, as well as looking at how the programs
might be improved.
Status | Active, not recruiting |
Enrollment | 1763 |
Est. completion date | September 2017 |
Est. primary completion date | June 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 3 Months to 12 Months |
Eligibility |
Inclusion Criteria: - Mother of child between the ages of 3 and 12 months and her child Exclusion Criteria: |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
United States | International Food Policy Research Institute | Washington | District of Columbia |
Lead Sponsor | Collaborator |
---|---|
International Food Policy Research Institute | Bill and Melinda Gates Foundation, United States Agency for International Development (USAID) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Growth | Change in height-for-age Z-scores, weight-for-age Z-scores and weight-for-height Z-scores will be measured as well as the change in the prevalence of stunting (HAZ <-2), underweight (WAZ <-2) and wasting (WHZ <-2) over the course of the two year program period. | Measurements will be made for children between the ages of 3 and 12 months of age at baseline and then 2 years later, at endline, when the children are between the ages of 23 and 40 months | No |
Primary | Hemoglobin | Measurements will be made for children between the ages of 3 and 12 months of age at baseline and then 2 years later, at endline, when the children are between the ages of 23 and 40 months | No | |
Secondary | Food security | Baseline (2010), Endline (2012), follow-up (2013) | No | |
Secondary | Household assets | Baseline (2010), Endline (2012), follow-up (2013) | No | |
Secondary | Household consumption | Baseline (2010), Endline (2012), follow-up (2013) | No | |
Secondary | Household livestock holdings | Baseline (2010), Endline (2012), follow-up (2013) | Yes | |
Secondary | Dietary diversity | Baseline (2010), Endline (2012), follow-up (2013) | No | |
Secondary | Mother's BMI | Baseline (2010), Endline (2012), follow-up (2013) | No | |
Secondary | Maternal health and nutrition-related knowledge | Baseline (2010), Endline (2012), follow-up (2013) | No | |
Secondary | IYCF practices | Baseline (2010), Endline (2012), follow-up (2013) | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00801931 -
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
|
Phase 1/Phase 2 | |
Completed |
NCT02948283 -
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
Completed |
NCT03341338 -
Genes-in-Action - Hepcidin Regulation of Iron Supplementation
|
||
Completed |
NCT00060398 -
Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
|
Phase 3 | |
Recruiting |
NCT05384691 -
Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions
|
Phase 2 | |
Not yet recruiting |
NCT06309641 -
Methemoglobinemia Following Intravenous Iron Treatment
|
||
Completed |
NCT02912494 -
A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT02930850 -
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
|
N/A | |
Completed |
NCT02912533 -
A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT02888171 -
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
|
N/A | |
Completed |
NCT03822884 -
Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02384122 -
Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias
|
Phase 3 | |
Completed |
NCT02603250 -
Evaluation of Hemoglobin Measurement Tools for Child Anemia Screening in Rwanda
|
N/A | |
Completed |
NCT02176759 -
Iron Absorption From Rice Fortified With Ferric Pyrophosphate
|
N/A | |
Completed |
NCT02310113 -
Transfusion and Skeletal Muscle Tissue Oxygenation
|
N/A | |
Completed |
NCT01922479 -
Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure
|
Phase 4 | |
Withdrawn |
NCT01934842 -
A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate
|
N/A | |
Completed |
NCT01693029 -
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
|
Phase 3 | |
Completed |
NCT01432717 -
Study of ACE-536 in Healthy Postmenopausal Women
|
Phase 1 | |
Terminated |
NCT01535781 -
Study of the Effect of Tranexamic Acid Administered to Patients With Hip Fractures. Can Blood Loss be Reduced?
|
N/A |